Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK, Aug. 8, 2023  /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer ("DTC") sales growth of 39.3%Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%.Net incom

Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the

Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK, May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer ("DTC") sales growth of 41.0%Gross profit grew 16.3% year-over-year to $34.3 million; gross p

NEW YORK, May 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its first quarter 2023 financial results after market close on Thurs, May 11, 2023. The company will host a conference call to discuss its results on Thurs, May 11, 2023, at 5:30 p.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com. The conference call can also be accessed b

Net Sales Growth of 24.1% and Adj. EBITDA1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance NEW YORK, March 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, today announced its financial results for the fourth quarter and full-year ended December 31, 2022. Fourth Quarter 2022 Highlights: Net sales grew 27.7% year-over-year to $63.0 million, with direct-to-consumer ("DTC") sales growth of 46.1%Gross p

NEW YORK, March 29, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its fourth quarter and full-year 2022 financial results after market close on Thurs, Mar. 30, 2023. The company will host a conference call to discuss its results on Fri, Mar. 31, 2023, at 8 a.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com.   The conference call can a

Acquisition of PreCon strengthens brain health portfolio and provides access to world-class scientific advisory board NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced it has acquired all of the outstanding stock of PreCon Health, Inc. ("PreCon"), a company focused on scientific discovery, innovation, and advancing safe and effective products that support healthy brain function. The acquisition was completed on January 31, 2023, for an aggregate purchase price of $5.0 million.

Updates Full-Year 2022 Guidance NEW YORK, Nov. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in developing personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the third quarter ended September 30, 2022. Third Quarter Highlights: Net sales grew 21.7% year-over-year to $58.4 million, with direct-to-consumer ("DTC") sales growth of 47.2%Gross profit grew 10.3% year-over-year to $28.2 million; gross margin decreased 500 basis

NEW YORK, Oct. 18, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, will release its third quarter 2022 financial results after market close on Wednesday, Nov. 09, 2022. The company will host a conference call to discuss its results on Thursday, Nov. 10, 2022, at 8 a.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the company's website at https://investors.thornehealthtech.com. The conference call can also be ac

Revises Full-Year 2022 Guidance NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in developing personalized, innovative solutions to help people live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2022. Second Quarter Highlights: Net sales grew 30.7% year-over-year to $56.1 million, with direct-to-consumer (DTC) sales growth of 69.6%Gross profit grew 37.0% year-over-year to $31.4 million; gross margin increased 260 basis points year over

NEW YORK, March 13, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (NASDAQ:THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced that it has appointed Saloni Varma as Chief Financial Officer (CFO). As CFO, Varma will lead all aspects of the company's Accounting and Finance functions including budgeting planning and analysis, accounting, SEC reporting, tax, treasury, and investor relations. Varma brings more than 20 years of experience across a range of consumer goods companies, mos

NEW YORK, Oct. 13, 2023 /PRNewswire/ -- L Catterton and Thorne HealthTech, Inc. ("Thorne") (NASDAQ:THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ("Shares") for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the "Offer"), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the "Expiration Time"). Computershare Trust Company, N.A., the depositary and paying agent for the Offer, has advised L Catterton that, as of the Expiration Time, 52,596,517 Shares were validly tendered and not validly

NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) -- Abcam Plc (NASDAQ:ABCM) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of ABCM to Danaher Corporation for $24.00 per share in cash for each share of ABCM common stock owned. If you are an ABCM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected]. Thorne HealthTech, Inc. (NASDAQ:THRN) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of TRHN to L Catter

L Catterton to Commence a Tender Offer for all of Thorne's Outstanding Shares of Common Stock Thorne Stockholders to Receive $10.20 per Share in Cash, Representing a 94% Premium to the Unaffected Price Independent Special Committee and Thorne Board of Directors Unanimously Approve Transaction and Recommend that All Stockholders Tender Their Shares in the Tender Offer  NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it has entered into a definitive agreement under which L Catterton, a leading global consumer-focused inv

Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK, Aug. 8, 2023  /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer ("DTC") sales growth of 39.3%Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%.Net incom

Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK, Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m. (U.S. Eastern Time). A live webcast and replay of the call will be available on the investors section of the

NEW YORK, July 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in the Canaccord Genuity 43rd Annual Growth Conference in Boston. On Thursday, Aug. 10, at 10:30 a.m. (U.S. Eastern Daylight Time), Thorne's Chairman and CEO, Paul Jacobson and the Company's CFO, Saloni Varma, will participate in a fireside chat. Mr. Jacobson and Ms. Varma will also conduct one-on-one meetings with investors at the confe

NEW YORK, June 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that its NanoDrop device has received a CE (Conformite Europeenne) Mark certification and has successfully fulfilled the European Union's relevant performance, safety, and product requirements. NanoDrop expands Thorne's line of innovative health-care solutions, bringing virtually painless blood collection to decentralized clinical trials and at-home diagnostic testing. The clin

NEW YORK, May 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in TD Cowen's 7th Annual Future of the Consumer Conference in New York City. On Wednesday, June 7, at 10:45 a.m. (U.S. Eastern Daylight Time), Thorne's Chairman and CEO, Paul Jacobson will participate in a panel discussion. Mr. Jacobson, and the Company's CFO, Saloni Varma, will also conduct one-on-one meetings with investors at the confe

NEW YORK, May 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it is entering into a research and development partnership agreement with Arome Science, a leader in metabolomics, to develop a next-generation metabolomics test. Arome Science and Thorne will collaborate to develop a commercial metabolomics wellness test. The test will be used to support research studies using at-home blood collection via Thorne's OneDraw® medical device,

Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK, May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ:THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer ("DTC") sales growth of 41.0%Gross profit grew 16.3% year-over-year to $34.3 million; gross p

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4 - Thorne Healthtech, Inc. (0001844280) (Issuer)

4/A - Thorne Healthtech, Inc. (0001844280) (Issuer)

4/A - Thorne Healthtech, Inc. (0001844280) (Issuer)

4/A - Thorne Healthtech, Inc. (0001844280) (Issuer)

4/A - Thorne Healthtech, Inc. (0001844280) (Issuer)

SC 13G/A - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G/A - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G/A - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 13G - Thorne Healthtech, Inc. (0001844280) (Subject)

15-12G - Thorne Healthtech, Inc. (0001844280) (Filer)

S-8 POS - Thorne Healthtech, Inc. (0001844280) (Filer)

S-8 POS - Thorne Healthtech, Inc. (0001844280) (Filer)

S-8 POS - Thorne Healthtech, Inc. (0001844280) (Filer)

25-NSE - Thorne Healthtech, Inc. (0001844280) (Subject)

8-K - Thorne Healthtech, Inc. (0001844280) (Filer)

SC 14D9/A - Thorne Healthtech, Inc. (0001844280) (Subject)

SC 14D9/A - Thorne Healthtech, Inc. (0001844280) (Subject)

8-K - Thorne Healthtech, Inc. (0001844280) (Filer)

8-K - Thorne Healthtech, Inc. (0001844280) (Filer)

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Hostess Brands, Inc. (NASDAQ:TWNK) The J. M. Smucker announced plans to acquire Hostess Brands for $34.25 per share, implying a total enterprise value of $5.6 billion. Th

Upgrades For Coherent Corp (NYSE:COHR), B. Riley Securities upgraded the previous rating of Neutral to Buy. In the fourth quarter, Coherent showed an EPS of $0.41, compared to $0.98 from the year-ago quarter. The current stock performance of Coherent shows a 52-week-high of $60.46 and a 52-week-low of $26.29. Moreover, at the end of the last trading period, the closing price was at $33.06. Barclays upgraded the previous rating for PPG Industries Inc (NYSE:PPG) from Equal-Weight to Overweight. For the second quarter, PPG Indus had an EPS of $2.25, compared to year-ago quarter EPS of $1.81. The stock has a 52-week-high of $152.89 and a 52-week-low of $107.46. At the end of the last trading

Evercore ISI Group analyst Elizabeth Anderson downgrades Thorne HealthTech (NASDAQ:THRN) from Outperform to Neutral.

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Blue Apron Holdings, Inc. (NASDAQ:APRN) Blue Apron announced an agreement to be acquired by Wonder Group for $13 per share. The company’s stock has a 52-week high of $56.

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Casey's General Stores, Inc. (NASDAQ:CASY) Casey’s General Stores reported a first-quarter FY24 sales decline of 13.2% year-on-year to $3.87 billion, missing the analyst

The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Lifeway Foods, Inc. (NASDAQ:LWAY) Lifeway Foods reported a year-over-year increase in second-quarter EPS results and better-than-expected sales results. The company’s sto

Upgrades Goldman Sachs upgraded the previous rating for PDD Holdings Inc (NASDAQ:PDD) from Neutral to Buy. PDD Holdings earned $1.44 in the second quarter, compared to $1.13 in the year-ago quarter. The current stock performance of PDD Holdings shows a 52-week-high of $106.38 and a 52-week-low of $38.80. Moreover, at the end of the last trading period, the closing price was at $93.22. For UDR Inc (NYSE:UDR), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. For the second quarter, UDR had an EPS of $0.61, compared to year-ago quarter EPS of $0.57. The current stock performance of UDR shows a 52-week-high of $48.31 and a 52-week-low of $37.18. Moreover, at the

TD Cowen analyst Oliver Chen downgrades Thorne HealthTech (NASDAQ:THRN) from Outperform to Market Perform and raises the price target from $8 to $10.2.

Gainers Mobile Infrastructure Corporation (NASDAQ:BEEP) shares jumped 98.7% to $12.02. GD Culture Group Limited (NASDAQ:GDC) gained 61.8% to $4.11 after it announced the launch of live-streaming e-commerce business on TikTok, a popular social media platform. Hersha Hospitality Trust (NYSE:HT) shares climbed 56.5% to $9.82 after it announced a merger with KSL Capital Partners LLC, an investor in travel and leisure businesses. Bionomics Limited (NASDAQ:BNOX) rose 54% to $2.3550. Hawaiian Electric Industries, Inc. (NYSE:HE) gained 41.8% to $13.70 after the company released an in-depth response to the lawsuit recently filed by the County of Maui surrounding the tragic fires on August 8.

Thorne HealthTech Inc (NASDAQ:THRN) has entered into a definitive agreement to be acquired by L Catterton, a global consumer-focused investment firm, at $10.20 per share in cash. The transaction value of about $680 million represents a 94% premium to the unaffected closing share price on July 20, 2023, and a 30% premium to the last closing price of $7.81 on August 25, 2023. Thorne's independent special committee and Board of Directors have each unanimously approved the agreement and recommended that all stockholders tender their shares in the tender offer. "Together with their deep expertise in the health and wellness industry, global reach, and extensive operational capabilities, I am co